Daniel N. Swisher Jr.
CIK: 0001323113
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- May 21, 2026CORT
CORCEPT THERAPEUTICS INC
Award(A)DirectStock Option (right to buy)
12.5K shares- - Oct 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $87.54$193K - Oct 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $14.08$31K - Sep 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $72.45$159K - Sep 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $14.08$31K - Aug 11, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $14.08$31K - Aug 11, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $72.30$159K - Jul 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $71.08$156K - Jul 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $14.08$31K - Jun 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $70.61$155K - Jun 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $14.08$31K - Jun 10, 2025CORT
CORCEPT THERAPEUTICS INC
Award(A)DirectStock option (right to buy)
15K shares- - Jun 3, 2025CERS
CERUS CORP
Award(A)Direct60K shares- - May 12, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct400 shares at avg. $14.08$6K - May 12, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct1.8K shares at avg. $72.17$130K - May 12, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct400 shares at avg. $71.55$29K - May 12, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct1.8K shares at avg. $12.13$22K - Apr 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $70.22$154K - Apr 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $12.13$27K - Mar 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $53.60$118K - Mar 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $12.13$27K - Feb 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $68.08$150K - Feb 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $12.13$27K - Jan 10, 2025CORT
CORCEPT THERAPEUTICS INC
Exercise(M)Direct2.2K shares at avg. $12.13$27K - Jan 10, 2025CORT
CORCEPT THERAPEUTICS INC
Sale(S)Direct2.2K shares at avg. $50.54$111K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 | CORT CORCEPT THERAPEUTICS INC | Award(A) Stock Option (right to buy) | 12,500 | - | - | Direct |
| Oct 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $87.54 | $192,588 | Direct |
| Oct 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $14.08 | $30,976 | Direct |
| Sep 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $72.45 | $159,390 | Direct |
| Sep 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $14.08 | $30,976 | Direct |
| Aug 11, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $14.08 | $30,976 | Direct |
| Aug 11, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $72.30 | $159,060 | Direct |
| Jul 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $71.08 | $156,376 | Direct |
| Jul 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $14.08 | $30,976 | Direct |
| Jun 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $70.61 | $155,342 | Direct |
| Jun 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $14.08 | $30,976 | Direct |
| Jun 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Award(A) Stock option (right to buy) | 15,000 | - | - | Direct |
| Jun 3, 2025 | CERS CERUS CORP | Award(A) | 60,000 | - | - | Direct |
| May 12, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 400 | $14.08 | $5,632 | Direct |
| May 12, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 1,800 | $72.17 | $129,906 | Direct |
| May 12, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 400 | $71.55 | $28,620 | Direct |
| May 12, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 1,800 | $12.13 | $21,834 | Direct |
| Apr 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $70.22 | $154,484 | Direct |
| Apr 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $12.13 | $26,686 | Direct |
| Mar 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $53.60 | $117,920 | Direct |
| Mar 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $12.13 | $26,686 | Direct |
| Feb 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $68.08 | $149,776 | Direct |
| Feb 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $12.13 | $26,686 | Direct |
| Jan 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise(M) | 2,200 | $12.13 | $26,686 | Direct |
| Jan 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Sale(S) | 2,200 | $50.54 | $111,188 | Direct |
1-25 of 29 transactions
About Swisher Daniel N JR
Swisher Daniel N JR (SEC CIK 0001323113) files insider reports with the SEC as Director of CORCEPT THERAPEUTICS INC (CORT) and Director of CERUS CORP (CERS).
Signal8 holds 14 ownership filings by Swisher Daniel N JR, all Form 4s, filed between Nov 13, 2024 and May 26, 2026. Those filings report 29 transactions, from Nov 11, 2024 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Swisher Daniel N JR's filings is in REDWOOD CITY, CA.
Recent filings by Swisher Daniel N JR
- May 21, 2026: Grant or award of CORT derivative securities (Form 4, code A).
- Oct 10, 2025: Open-market sale of CORT shares (Form 4, code S).
- Oct 10, 2025: Option exercise of CORT shares (Form 4, code M).
- Sep 10, 2025: Open-market sale of CORT shares (Form 4, code S).
- Sep 10, 2025: Option exercise of CORT shares (Form 4, code M).
Other insiders filing for CORCEPT THERAPEUTICS INC (CORT)
- WILSON JAMES N, Director
- Vieira Roberto Wandenkolk, President, Oncology
- Lyon Joseph Douglas
- Maduck Sean
- Gunn Justin Frederick
- Robb Gary Charles, Chief Business Officer